Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.prnewswire.com/news-releases/registrational-phase-iii-clarify-trial-in-prostate-cancer-commences-302001515.html
Nov 30, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next